<DOC>
	<DOCNO>NCT00002280</DOCNO>
	<brief_summary>The purpose study make didanosine ( ddI ) available child AIDS clinically deteriorate zidovudine ( AZT ) intolerant AZT enter Phase II ddI program due protocol exclusion geographic location .</brief_summary>
	<brief_title>A Study ddI Children With AIDS Who Have Not Had Success With Zidovudine</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Concomitant medication treatment complication AIDS . CAUTION : Concomitant use ddI follow drug must do extreme caution : Other nucleoside ( e.g. , ganciclovir ) . Drugs toxicities similar observe ddI ( e.g. , phenytoin ) . Drugs significant pancreatic toxicity , include many drug use treatment major opportunistic infection . Use Sulfonamides intravenous pentamidine treatment acute Pneumocystis carinii pneumonia ( PCP ) require discontinuation ddI week follow treatment PCP . Caution also exercise patient intractable diarrhea patient follow low sodium diet . Patients must follow : Diagnosis AIDS . Demonstrated either significant deterioration despite parenteral dose zidovudine ( AZT ) significant intolerance AZT . Signed informed consent parent legal guardian . Evaluations every 714 day take ddI first 4 month . Monthly followup require thereafter . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Acute pancreatitis history pancreatitis . Seizures history seizure disorder . Grade I great peripheral neuropathy . Preexisting cardiomyopathy . Concurrent Medication : Excluded : Zidovudine ( AZT ) . Chemotherapy cytotoxic agent . AVOID : Those agent may cause pancreatitis : Pentamidine . Sulfonamides . Antituberculosis drug . Cimetidine . Ranitidine . Corticosteroids . NOTE cautionary statement Patient Inclusion Concurrent Medication . Patients follow exclude : Acute pancreatitis history pancreatitis . Seizures history seizure disorder . Grade I great peripheral neuropathy . Preexisting cardiomyopathy . Prior Medication : Excluded within 15 day study entry : Any antiretroviral except zidovudine ( AZT ) . Required : Zidovudine ( AZT ) .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Didanosine</keyword>
	<keyword>Drugs , Investigational</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
</DOC>